Multicomponent quality improvement intervention
Related entities
Findings (27)
None
declineOverall, only 16.3% (95% CI: 14.6-18.1) of participants with poorly controlled type 2 diabetes at baseline achieved guideline-recommended glycemic control (HbA1c <7%) over the study period, while 34.9
Effect: decline; 16.3%; CI: 95% CI: 14.6, 18.1
None
declineOverall, only 16.3% (95% CI: 14.6-18.1) of participants with poorly controlled type 2 diabetes at baseline achieved guideline-recommended glycemic control (HbA1c <7%) over the study period, while 34.9
Effect: decline; 16.3%; CI: 95% CI: 14.6, 18.1
None
declineOverall, only 16.3% (95% CI: 14.6-18.1) of participants with poorly controlled type 2 diabetes at baseline achieved guideline-recommended glycemic control (HbA1c <7%) over the study period, while 34.9
Effect: decline; 16.3%; CI: 95% CI: 14.6, 18.1
None
declineOverall, only 16.3% (95% CI: 14.6-18.1) of participants with poorly controlled type 2 diabetes at baseline achieved guideline-recommended glycemic control (HbA1c <7%) over the study period, while 34.9
Effect: decline; 16.3%; CI: 95% CI: 14.6, 18.1
None
declineOverall, only 16.3% (95% CI: 14.6-18.1) of participants with poorly controlled type 2 diabetes at baseline achieved guideline-recommended glycemic control (HbA1c <7%) over the study period, while 34.9
Effect: decline; 16.3%; CI: 95% CI: 14.6, 18.1
None
declineOverall, only 16.3% (95% CI: 14.6-18.1) of participants with poorly controlled type 2 diabetes at baseline achieved guideline-recommended glycemic control (HbA1c <7%) over the study period, while 34.9
Effect: decline; 16.3%; CI: 95% CI: 14.6, 18.1
None
declineOverall, only 16.3% (95% CI: 14.6-18.1) of participants with poorly controlled type 2 diabetes at baseline achieved guideline-recommended glycemic control (HbA1c <7%) over the study period, while 34.9
Effect: decline; 16.3%; CI: 95% CI: 14.6, 18.1
None
declineOverall, only 16.3% (95% CI: 14.6-18.1) of participants with poorly controlled type 2 diabetes at baseline achieved guideline-recommended glycemic control (HbA1c <7%) over the study period, while 34.9
Effect: decline; 16.3%; CI: 95% CI: 14.6, 18.1
None
declineOverall, only 16.3% (95% CI: 14.6-18.1) of participants with poorly controlled type 2 diabetes at baseline achieved guideline-recommended glycemic control (HbA1c <7%) over the study period, while 34.9
Effect: decline; 16.3%; CI: 95% CI: 14.6, 18.1
None
declineOverall, only 16.3% (95% CI: 14.6-18.1) of participants with poorly controlled type 2 diabetes at baseline achieved guideline-recommended glycemic control (HbA1c <7%) over the study period, while 34.9
Effect: decline; 16.3%; CI: 95% CI: 14.6, 18.1
None
declineOverall, only 16.3% (95% CI: 14.6-18.1) of participants with poorly controlled type 2 diabetes at baseline achieved guideline-recommended glycemic control (HbA1c <7%) over the study period, while 34.9
Effect: decline; 16.3%; CI: 95% CI: 14.6, 18.1
None
declineOverall, only 16.3% (95% CI: 14.6-18.1) of participants with poorly controlled type 2 diabetes at baseline achieved guideline-recommended glycemic control (HbA1c <7%) over the study period, while 34.9
Effect: decline; 16.3%; CI: 95% CI: 14.6, 18.1
None
declineOverall, only 16.3% (95% CI: 14.6-18.1) of participants with poorly controlled type 2 diabetes at baseline achieved guideline-recommended glycemic control (HbA1c <7%) over the study period, while 34.9
Effect: decline; 16.3%; CI: 95% CI: 14.6, 18.1
None
declineOverall, only 16.3% (95% CI: 14.6-18.1) of participants with poorly controlled type 2 diabetes at baseline achieved guideline-recommended glycemic control (HbA1c <7%) over the study period, while 34.9
Effect: decline; 16.3%; CI: 95% CI: 14.6, 18.1
None
declineOverall, only 16.3% (95% CI: 14.6-18.1) of participants with poorly controlled type 2 diabetes at baseline achieved guideline-recommended glycemic control (HbA1c <7%) over the study period, while 34.9
Effect: decline; 16.3%; CI: 95% CI: 14.6, 18.1
None
declineOverall, only 16.3% (95% CI: 14.6-18.1) of participants with poorly controlled type 2 diabetes at baseline achieved guideline-recommended glycemic control (HbA1c <7%) over the study period, while 34.9
Effect: decline; 16.3%; CI: 95% CI: 14.6, 18.1
None
declineOverall, only 16.3% (95% CI: 14.6-18.1) of participants with poorly controlled type 2 diabetes at baseline achieved guideline-recommended glycemic control (HbA1c <7%) over the study period, while 34.9
Effect: decline; 16.3%; CI: 95% CI: 14.6, 18.1
None
declineOverall, only 16.3% (95% CI: 14.6-18.1) of participants with poorly controlled type 2 diabetes at baseline achieved guideline-recommended glycemic control (HbA1c <7%) over the study period, while 34.9
Effect: decline; 16.3%; CI: 95% CI: 14.6, 18.1
None
declineOverall, only 16.3% (95% CI: 14.6-18.1) of participants with poorly controlled type 2 diabetes at baseline achieved guideline-recommended glycemic control (HbA1c <7%) over the study period, while 34.9
Effect: decline; 16.3%; CI: 95% CI: 14.6, 18.1
None
declineOverall, only 16.3% (95% CI: 14.6-18.1) of participants with poorly controlled type 2 diabetes at baseline achieved guideline-recommended glycemic control (HbA1c <7%) over the study period, while 34.9
Effect: decline; 16.3%; CI: 95% CI: 14.6, 18.1
None
declineOverall, only 16.3% (95% CI: 14.6-18.1) of participants with poorly controlled type 2 diabetes at baseline achieved guideline-recommended glycemic control (HbA1c <7%) over the study period, while 34.9
Effect: decline; 16.3%; CI: 95% CI: 14.6, 18.1
None
declineOverall, only 16.3% (95% CI: 14.6-18.1) of participants with poorly controlled type 2 diabetes at baseline achieved guideline-recommended glycemic control (HbA1c <7%) over the study period, while 34.9
Effect: decline; 16.3%; CI: 95% CI: 14.6, 18.1
None
declineOverall, only 16.3% (95% CI: 14.6-18.1) of participants with poorly controlled type 2 diabetes at baseline achieved guideline-recommended glycemic control (HbA1c <7%) over the study period, while 34.9
Effect: decline; 16.3%; CI: 95% CI: 14.6, 18.1
None
declineOverall, only 16.3% (95% CI: 14.6-18.1) of participants with poorly controlled type 2 diabetes at baseline achieved guideline-recommended glycemic control (HbA1c <7%) over the study period, while 34.9
Effect: decline; 16.3%; CI: 95% CI: 14.6, 18.1
None
declineOverall, only 16.3% (95% CI: 14.6-18.1) of participants with poorly controlled type 2 diabetes at baseline achieved guideline-recommended glycemic control (HbA1c <7%) over the study period, while 34.9
Effect: decline; 16.3%; CI: 95% CI: 14.6, 18.1
None
declineOverall, only 16.3% (95% CI: 14.6-18.1) of participants with poorly controlled type 2 diabetes at baseline achieved guideline-recommended glycemic control (HbA1c <7%) over the study period, while 34.9
Effect: decline; 16.3%; CI: 95% CI: 14.6, 18.1
None
declineOverall, only 16.3% (95% CI: 14.6-18.1) of participants with poorly controlled type 2 diabetes at baseline achieved guideline-recommended glycemic control (HbA1c <7%) over the study period, while 34.9
Effect: decline; 16.3%; CI: 95% CI: 14.6, 18.1